Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet? / Aabenhus, R.; Jensen, J.U.

In: Primary Care Respiratory Journal, Vol. 20, No. 4, 12.2011, p. 360-367.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Aabenhus, R & Jensen, JU 2011, 'Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?', Primary Care Respiratory Journal, vol. 20, no. 4, pp. 360-367.

APA

Aabenhus, R., & Jensen, J. U. (2011). Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet? Primary Care Respiratory Journal, 20(4), 360-367.

Vancouver

Aabenhus R, Jensen JU. Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet? Primary Care Respiratory Journal. 2011 Dec;20(4):360-367.

Author

Aabenhus, R. ; Jensen, J.U. / Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?. In: Primary Care Respiratory Journal. 2011 ; Vol. 20, No. 4. pp. 360-367.

Bibtex

@article{7868130a27334b5b87a7aa2783ecf343,
title = "Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?",
abstract = "Clinical signs of infection do not allow for correct identification of bacterial and viral aetiology in acute respiratory infections. A valid tool to assist the clinician in identifying patients who will benefit from antibiotic therapy, as well as patients with a potentially serious infection, could greatly improve patient care and limit excessive antibiotic prescriptions. Procalcitonin is a new marker of suspected bacterial infection that has shown promise in guiding antibiotic therapy in acute respiratory tract infections in hospitals without compromising patient safety. Procalcitonin concentrations in primary care are low and can be used primarily to rule out serious infection. However, procalcitonin measurement should not be used as the sole basis for clinical decisions; clinical skills are prerequisites for the correct use of this new tool in practice. At present there is no point-of-care test for procalcitonin with acceptable precision, severely hampering its application in primary care. This article reviews the physiology of procalcitonin, describes the assays available for its measurement, evaluates the present evidence from primary care on its use to identify correctly patients who are likely to benefit from antibiotic treatment and to rule out serious infections, and comments on further research to determine a future role for procalcitonin in primary care",
keywords = "care, Denmark, GENERAL-PRACTICE, general practice, PATIENT, Patients, physiology, Practice, PRIMARY-CARE, Research, semrap-2011-2, therapy",
author = "R. Aabenhus and J.U. Jensen",
year = "2011",
month = "12",
language = "English",
volume = "20",
pages = "360--367",
journal = "Primary Care Respiratory Journal",
issn = "1471-4418",
publisher = "Strategic Medical Publishing",
number = "4",

}

RIS

TY - JOUR

T1 - Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?

AU - Aabenhus, R.

AU - Jensen, J.U.

PY - 2011/12

Y1 - 2011/12

N2 - Clinical signs of infection do not allow for correct identification of bacterial and viral aetiology in acute respiratory infections. A valid tool to assist the clinician in identifying patients who will benefit from antibiotic therapy, as well as patients with a potentially serious infection, could greatly improve patient care and limit excessive antibiotic prescriptions. Procalcitonin is a new marker of suspected bacterial infection that has shown promise in guiding antibiotic therapy in acute respiratory tract infections in hospitals without compromising patient safety. Procalcitonin concentrations in primary care are low and can be used primarily to rule out serious infection. However, procalcitonin measurement should not be used as the sole basis for clinical decisions; clinical skills are prerequisites for the correct use of this new tool in practice. At present there is no point-of-care test for procalcitonin with acceptable precision, severely hampering its application in primary care. This article reviews the physiology of procalcitonin, describes the assays available for its measurement, evaluates the present evidence from primary care on its use to identify correctly patients who are likely to benefit from antibiotic treatment and to rule out serious infections, and comments on further research to determine a future role for procalcitonin in primary care

AB - Clinical signs of infection do not allow for correct identification of bacterial and viral aetiology in acute respiratory infections. A valid tool to assist the clinician in identifying patients who will benefit from antibiotic therapy, as well as patients with a potentially serious infection, could greatly improve patient care and limit excessive antibiotic prescriptions. Procalcitonin is a new marker of suspected bacterial infection that has shown promise in guiding antibiotic therapy in acute respiratory tract infections in hospitals without compromising patient safety. Procalcitonin concentrations in primary care are low and can be used primarily to rule out serious infection. However, procalcitonin measurement should not be used as the sole basis for clinical decisions; clinical skills are prerequisites for the correct use of this new tool in practice. At present there is no point-of-care test for procalcitonin with acceptable precision, severely hampering its application in primary care. This article reviews the physiology of procalcitonin, describes the assays available for its measurement, evaluates the present evidence from primary care on its use to identify correctly patients who are likely to benefit from antibiotic treatment and to rule out serious infections, and comments on further research to determine a future role for procalcitonin in primary care

KW - care

KW - Denmark

KW - GENERAL-PRACTICE

KW - general practice

KW - PATIENT

KW - Patients

KW - physiology

KW - Practice

KW - PRIMARY-CARE

KW - Research

KW - semrap-2011-2

KW - therapy

M3 - Journal article

VL - 20

SP - 360

EP - 367

JO - Primary Care Respiratory Journal

JF - Primary Care Respiratory Journal

SN - 1471-4418

IS - 4

ER -

ID: 37606434